Article Grading: The following comments were left by the quality and importance raters: (edit · history · refresh · how to use this template)
Would an anti-CD134 monoclonal antibody or immunoconjugate allow for selective destruction of RECENTLY activated T-cells ? If this is the case, presumably it could have many potential implications including Tx of graft-versus-host disease, and various new-onset T-cell mediated autoimmune diseases.
Any thoughts or info ?
|